Energy-conservation management in organizationsSELMER, J.International journal of energy research. 1993, Vol 17, Num 3, pp 221-227, issn 0363-907XArticle

A MODEL FOR THE EVALUATION OF ENERGY CONSERVATION INVESTMENTSRAPP B; SELMER J.1979; ENERGY AND BUILDGS; CHE; DA. 1979; VOL. 2; NO 3; PP. 203-208; BIBL. 6 REF.Article

Organizational determinants of energy-conservation managementSELMER, J.Energy (Oxford). 1994, Vol 19, Num 10, pp 1023-1030, issn 0360-5442Article

THE RISKS IN USING QUOTA MEASURES FOR EVALUATING ENERGY INVESTMENTSRAPP B; SELMER J.1981; RESOUR. ENERGY; ISSN 0165-0572; NLD; DA. 1981; VOL. 3; NO 4; PP. 389-399; BIBL. 10 REF.Article

INVESTING IN ENERGY PRODUCTION VS. ENERGY CONSERVATION: A COMPARISON OF FINANCIAL TERMS = INVESTIR DANS LA PRODUCTION D'ENERGIE OU DANS LES ECONOMIES D'ENERGIE: COMPARAISON D'AIDES FINANCIERESRAPP B; SELMER J.1979; ; SWE; LINKOEPING: SCBR; DA. 1979; SCBR/48; 22 P.; 30 CM; L34129/697Report

HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL FUNCTION IN CHRONIC ALCOHOLISMHASSELBALCH H; SELMER J; SESTOFT L et al.1982; CLIN. ENDOCRINOL. (OXF.); ISSN 0300-0664; GBR; DA. 1982; VOL. 16; NO 1; PP. 73-76; BIBL. 14 REF.Article

The risks in using quota measures for evaluating energy investments Les risques d'utilisation des mesures de quota pour l'évaluation des investissements énergétiquesRAPP, B; SELMER, J.Resources and Energy. 1981, Vol 3, Num 4, pp 389-399Article

Impact of organizational factors on energy conservation measures Impact des facteurs organisationnels sur les mesures de conservation de l'énergieRAPP, B; SELMER, J.Energy Policy. 1985, Vol 13, Num 5, pp 437-444Article

Biological background subtraction improves immunoscintigraphy by subsequent injection of antigenTROMHOLT, N; SELMER, J.JNM : (1990). 1991, Vol 32, Num 12, pp 2318-2321Article

New procedure for extraction of ammonium from natural waters for ¹⁵N isotopic ratio determinationsSELMER, J.-S; SORENSSON, F.Applied and environmental microbiology (Print). 1986, Vol 52, Num 3, pp 577-579, issn 0099-2240Article

Impact of organizational factors on energy conservation measuresRAPP, B; SELMER, J.Energy policy. 1985, Vol 13, Num 5, pp 437-444, issn 0301-4215Article

Native and degraded fibronectin: new immunological methods for distinctionSELMER, J; ERIKSEN, H; CLEMMENSEN, I et al.Scandinavian journal of clinical & laboratory investigation. 1984, Vol 44, Num 1, pp 57-63, issn 0036-5513Article

Influence of UV-B radiation on bacterial activity in coastal watersGUSTAVSON, K; GARDE, K; WÄNGBERG, S.-A et al.Journal of plankton research. 2000, Vol 22, Num 8, pp 1501-1511, issn 0142-7873Article

Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2THORSEN, S; PHILIPS, M; SELMER, J et al.European journal of biochemistry (Print). 1988, Vol 175, Num 1, pp 33-39, issn 0014-2956Article

Effects of UVB radiation on marine phytoplankton communitiesWÄNGBERG, S.-A; GARDE, K; GUSTAVSON, K et al.Journal of plankton research. 1999, Vol 21, Num 1, pp 147-166, issn 0142-7873Article

Purification of Bordetella pertussis antigens using monoclonal antibodiesLARSEN, F. S; SELMER, J. C; HERTZ, J. B et al.Acta pathologica, microbiologica et immunologica Scandinavica. Section C. Immunology. 1984, Vol 92, Num 5, pp 271-277, issn 0108-0202Article

Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?BOEL, E; SELMER, J; FLODGAARD, H. J et al.Journal of diabetes and its complications. 1995, Vol 9, Num 2, pp 104-129, issn 1056-8727Article

Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasmaJØGENSEN, M; PHILIPS, M; THORSEN, S et al.Thrombosis and haemostasis. 1987, Vol 58, Num 3, pp 872-878, issn 0340-6245Article

Isolation of human erythrocyte acetylcholinesterase using phase separation with triton X-114 and monoclonal immunosorbent chromatographyBJERRUM, O. J; SELMER, J; HANGAARD, J et al.Journal of applied biochemistry. 1985, Vol 7, Num 4-5, pp 356-369, issn 0161-7354Article

Purification and partial characterization of filamentous haemagglutinin from Bordetella pertussis using monoclonal antibodiesSELMER, J. C; LARSEN, F. S; HERTZ, J. B et al.Acta pathologica, microbiologica et immunologica Scandinavica. Section C. Immunology. 1984, Vol 92, Num 5, pp 279-284, issn 0108-0202Article

Detection of deep venous thrombosis with indium 111-labelled monoclonal antibody against tissue plasminogen activatorTROMHOLT, N; HESSE, B; FOLKENBORG, O et al.European journal of nuclear medicine. 1991, Vol 18, Num 5, pp 321-325, issn 0340-6997Article

Plasma and urine fibronectin concentration in kidney-transplanted patientsERIKSEN, H. O; SKJOLDBY, O; KJERSEM, H et al.Scandinavian journal of clinical & laboratory investigation. 1984, Vol 44, Num 2, pp 135-142, issn 0036-5513Article

Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placentaPHILIPS, M; JUUL, A.-G; THORSEN, S et al.Thrombosis and haemostasis. 1986, Vol 55, Num 2, pp 213-217, issn 0340-6245Article

A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoylated poly-D-lysine as a stimulator for plasminogen activationPETERSEN, L. C; HANDEST, P; BRENDER, J et al.Thrombosis and haemostasis. 1987, Vol 57, Num 2, pp 205-211, issn 0340-6245Article

A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma : standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic diseasePHILIPS, M; JUUL, A.-G; SELMER, J et al.Thrombosis and haemostasis. 1992, Vol 68, Num 5, pp 486-494, issn 0340-6245Article